Epstein Secrets

ic at large will more than offset this expense. The authors have no financial conflicts of interest to report. 7 EFTA_R1_01558199 EFTA02455526 Deepak Chopra MD, FACP, Clinical Professor of Medicine, University of California, San Diego, Chairman and Founder, The Chopra Foundation, Co•Founder, The Chopra Cent

From: Deepak Chopra Sent: Monday, August 1, 2016 12:29 PM To: Jef

ed in prohibitive and avoidable excess mortality and morbidity rates. One of the more recent drug approvals that was later withdrawn was in 2004 for Merck's anti- inflammatory drug Rofecoxib (Vioxx •) which has been conservatively attributed with over 38,000 deaths in the US, and 60,000 worldwide. The

Executive Officer Bharat Light and Power India Chopra Niels B. Christiansen President and Chief Execut

Secretary-General Chief Executive Officer Chief Executive Officer Managing Director, Legal and Risk Professor of Management Practice President, Merck Vaccines Director, Center for Public Leadership Artistic and General Director Managing Partner, Strategy and Business Development Managing Direc

Choi Ashwin C. Choksi Eric Chol Tejpreet Singh Chopra Niels B. Christiansen Victor L. L. Chu Amy Chu

and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Public Leadership Harvard Kennedy School USA Valery Gergiev Artistic and G

Choi Ashwin C. Choksi Eric Chol Tejpreet Singh Chopra Niels B. Christiansen Victor L. L. Chu Amy Chu

and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Public Leadership Harvard Kennedy School USA Valery Gergiev Artistic and G